therapy

AI-driven model enhances treatment decisions for cancer patients after heart attack

by

The Future of Heart Attack Care: Personalizing Treatment for Cancer Patients For decades, cancer patients experiencing heart attacks have been a uniquely vulnerable population, often excluded from vital research and lacking tailored treatment guidelines. This is changing. A groundbreaking new risk prediction model, ONCO-ACS, developed by an international team led by the University of Zurich, … Read more

Targeted fab fragments dismantle the allergy trigger

by

A New Hope for Allergy Sufferers: Stripping IgE from Immune Cells Allergies are more than just a seasonal nuisance; they represent a significant and growing global health challenge. From life-threatening anaphylaxis to chronic conditions like asthma and rhinitis, allergic diseases place a heavy burden on individuals and healthcare systems. Current treatments often fall short, addressing … Read more

Researchers decipher a key mechanism that controls pancreatic cancer growth

by

Pancreatic Cancer Breakthrough: Unmasking Tumors to Unleash the Immune System A groundbreaking study published in Cell has revealed a surprising new way pancreatic cancer cells evade the body’s natural defenses. Researchers have identified a dual function of the MYC protein – traditionally known for driving cancer cell growth – that actively suppresses the immune response. … Read more

Expert guidance on fecal microbiota transplantation in liver disease

by

Fecal Microbiota Transplantation: A Gut Feeling About the Future of Liver Disease Treatment For decades, the gut has been seen as a digestive workhorse. Now, groundbreaking research is revealing its profound influence on nearly every aspect of our health, particularly liver function. Fecal Microbiota Transplantation (FMT) – the process of transferring fecal bacteria from a … Read more

Study finds no safety or efficacy gap between paracetamol and ibuprofen for neonatal PDA

by

Paracetamol vs. Ibuprofen for Premature Babies: A New Look at Treating Patent Ductus Arteriosus For decades, ibuprofen has been the go-to medication for treating patent ductus arteriosus (PDA) – a common heart condition in premature babies. But a recent pilot study, the PAIR trial, published in Frontiers in Pediatrics, suggests paracetamol might be a viable … Read more

Customizable protein platforms offer new hope for cancer treatment

by

Beyond Cancer: How ‘Cellular Reprogramming’ Could Revolutionize Disease Treatment A groundbreaking approach to manipulating proteins at the cellular level, pioneered at the University of Massachusetts Amherst, is poised to reshape the future of medicine. Researchers are developing techniques to not only destroy disease-causing proteins but also to ‘reprogram’ cells, essentially restoring them to healthy function. … Read more

Injectable nanomaterial reduces secondary brain injury after ischemic stroke

by

Beyond ‘Clot-Busting’: The Dawn of Regenerative Stroke Therapies For decades, stroke treatment has centered on a critical, time-sensitive goal: restoring blood flow. While vital, this approach – using “clot-busting” drugs or surgical clot removal – is only the first step. Emerging research reveals that the very act of restoring blood flow can unleash a secondary … Read more

New breakthrough could modernize treatment for glioblastoma

by

A New Dawn for Glioblastoma Treatment: Combining Chemotherapy with a Surprising Ally For decades, glioblastoma, one of the most aggressive forms of brain cancer, has stubbornly resisted effective treatment. Survival rates remain grim – around 7% beyond five years post-diagnosis. But a groundbreaking study from the UNC School of Medicine and UNC Eshelman School of … Read more

Silica nanomatrix enhances immunotherapy for solid tumors

by

Revolutionizing Cancer Treatment: How Nanotechnology is Supercharging Immunotherapy For years, immunotherapy – harnessing the body’s own immune system to fight cancer – has held immense promise. But challenges remain. Current dendritic cell (DC) therapy, a key immunotherapy approach, can be expensive, complex to manufacture, and yield inconsistent results. Now, a breakthrough from researchers at The … Read more

Combination therapy offers hope for AML patients facing drug resistance

by

AML Treatment Breakthrough: Could Breast Cancer Drugs Hold the Key? Acute myeloid leukemia (AML), a rapidly progressing cancer of the blood and bone marrow, affects over 20,000 Americans annually. While the introduction of venetoclax in 2019, combined with azacitidine, offered a significant step forward in treatment, the development of drug resistance remains a major hurdle. … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]